A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.


Updates from The Motley Fool

Latest updates on Merck & Co. from Fool.com.  The Fool has written over 1600 articles on Merck & Co..
Is Merck & Co. Inc. a Buy?

Merck just might be poised for a rebound. But is the stock a smart long-term pick?



Stock Performance

View Interactive MRK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Merck & Co..
Current Price: $58.59
Prev Close: $59.14
Open: $59.18
Bid: $58.66
Ask: $58.67
Day's Range: $58.65 - $59.32
52wk Range: $52.83 - $66.41
Volume: 2,877,783
Avg Vol 11,760,258
Market Cap: $160B
P/E (ttm): 67.98
EPS (ttm): $0.87
Div & Yield: $1.92 (3.2%)

Company Rating

What our community thinks about Merck & Co..
CAPS Rating 3 out of 5
 
2705 Outperform
221 Underperform
CAPS All Stars
 
547 Outperform
30 Underperform

How do you think Merck & Co. will perform against the market?



You pick for Merck & Co. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kenneth C. Frazier, CEO

79% Approve

Based on 971 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Merck & Co..

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers